SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001393825-17-000008
Filing Date
2017-01-30
Accepted
2017-01-30 10:23:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROTAGENIC THERAPEUTICS, INC SC13GA ptix_sc13GA.txt SC 13G/A 11920
  Complete submission text file 0001393825-17-000008.txt   13808
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Subject) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48089 | Film No.: 17555682
SIC: 7389 Services-Business Services, NEC

Mailing Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017 212-571-1244
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

IRS No.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A